Recommendations Updated for Recombinant Zoster Vaccine
THURSDAY, Jan. 20, 2022 -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Herpes | Pharmaceuticals | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine